Martine Lapalus

EASL Clinical Practice Guidelines on the management of hepatitis B virus infection

AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA

Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients